Cargando…

Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets

Diabetes Mellitus (DM) is a worldwide health issue that can lead to a variety of complications. DM is a serious metabolic disorder that causes long-term microvascular and macro-vascular complications, as well as the failure of various organ systems. Diabetes-related cardiovascular diseases (CVD) inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mengstie, Misganaw Asmamaw, Abebe, Endeshaw Chekol, Teklemariam, Awgichew Behaile, Mulu, Anemut Tilahun, Teshome, Assefa Agegnehu, Zewde, Edgeit Abebe, Muche, Zelalem Tilahun, Azezew, Muluken Teshome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478122/
https://www.ncbi.nlm.nih.gov/pubmed/36120460
http://dx.doi.org/10.3389/fendo.2022.947294
_version_ 1784790497412251648
author Mengstie, Misganaw Asmamaw
Abebe, Endeshaw Chekol
Teklemariam, Awgichew Behaile
Mulu, Anemut Tilahun
Teshome, Assefa Agegnehu
Zewde, Edgeit Abebe
Muche, Zelalem Tilahun
Azezew, Muluken Teshome
author_facet Mengstie, Misganaw Asmamaw
Abebe, Endeshaw Chekol
Teklemariam, Awgichew Behaile
Mulu, Anemut Tilahun
Teshome, Assefa Agegnehu
Zewde, Edgeit Abebe
Muche, Zelalem Tilahun
Azezew, Muluken Teshome
author_sort Mengstie, Misganaw Asmamaw
collection PubMed
description Diabetes Mellitus (DM) is a worldwide health issue that can lead to a variety of complications. DM is a serious metabolic disorder that causes long-term microvascular and macro-vascular complications, as well as the failure of various organ systems. Diabetes-related cardiovascular diseases (CVD) including heart failure cause significant morbidity and mortality worldwide. Concurrent hypertensive heart disease and/or coronary artery disease have been thought to be the causes of diabetic heart failure in DM patients. However, heart failure is extremely common in DM patients even in the absence of other risk factors such as coronary artery disease and hypertension. The occurrence of diabetes-induced heart failure has recently received a lot of attention. Understanding how diabetes increases the risk of heart failure and how it mediates major cellular and molecular alteration will aid in the development of therapeutics to prevent these changes. Hence, this review aimed to summarize the current knowledge and most recent findings in cellular and molecular mechanisms of diabetes-induced heart failure.
format Online
Article
Text
id pubmed-9478122
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94781222022-09-17 Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets Mengstie, Misganaw Asmamaw Abebe, Endeshaw Chekol Teklemariam, Awgichew Behaile Mulu, Anemut Tilahun Teshome, Assefa Agegnehu Zewde, Edgeit Abebe Muche, Zelalem Tilahun Azezew, Muluken Teshome Front Endocrinol (Lausanne) Endocrinology Diabetes Mellitus (DM) is a worldwide health issue that can lead to a variety of complications. DM is a serious metabolic disorder that causes long-term microvascular and macro-vascular complications, as well as the failure of various organ systems. Diabetes-related cardiovascular diseases (CVD) including heart failure cause significant morbidity and mortality worldwide. Concurrent hypertensive heart disease and/or coronary artery disease have been thought to be the causes of diabetic heart failure in DM patients. However, heart failure is extremely common in DM patients even in the absence of other risk factors such as coronary artery disease and hypertension. The occurrence of diabetes-induced heart failure has recently received a lot of attention. Understanding how diabetes increases the risk of heart failure and how it mediates major cellular and molecular alteration will aid in the development of therapeutics to prevent these changes. Hence, this review aimed to summarize the current knowledge and most recent findings in cellular and molecular mechanisms of diabetes-induced heart failure. Frontiers Media S.A. 2022-09-02 /pmc/articles/PMC9478122/ /pubmed/36120460 http://dx.doi.org/10.3389/fendo.2022.947294 Text en Copyright © 2022 Mengstie, Abebe, Teklemariam, Mulu, Teshome, Zewde, Muche and Azezew https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Mengstie, Misganaw Asmamaw
Abebe, Endeshaw Chekol
Teklemariam, Awgichew Behaile
Mulu, Anemut Tilahun
Teshome, Assefa Agegnehu
Zewde, Edgeit Abebe
Muche, Zelalem Tilahun
Azezew, Muluken Teshome
Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
title Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
title_full Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
title_fullStr Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
title_full_unstemmed Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
title_short Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
title_sort molecular and cellular mechanisms in diabetic heart failure: potential therapeutic targets
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478122/
https://www.ncbi.nlm.nih.gov/pubmed/36120460
http://dx.doi.org/10.3389/fendo.2022.947294
work_keys_str_mv AT mengstiemisganawasmamaw molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets
AT abebeendeshawchekol molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets
AT teklemariamawgichewbehaile molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets
AT muluanemuttilahun molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets
AT teshomeassefaagegnehu molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets
AT zewdeedgeitabebe molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets
AT muchezelalemtilahun molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets
AT azezewmulukenteshome molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets